Company intelligence / Profile preview

GiddiRare

Taichung, Taichung, Taiwancn.linkedin.com ↗

Ownership: Private
Employees: ~64
Development stage: Other

Overview

Giddi Pharma is a leading specialty pharmaceutical distributor in Taiwan focused on commercializing orphan drugs and specialty products for pediatric genetic, metabolic, and neurological disorders. The company has received multiple awards for its contributions to rare disease medication supply and distribution. It partners with global companies such as Genzyme, BioMarin, Ipsen among others. Clinical results are not applicable as it does not develop its own pipeline but rather distributes approved therapies from international partners.

Therapeutic areas: Metabolic DisordersRare DiseasesNeurology
Modalities: Small moleculeBiologicEnzyme replacement therapy
Industry: Non-Academic Healthcare

Partnerships

GenzymeBioMarinIpsen

Beyond the preview

Go deeper on GiddiRare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GiddiRare.

Explore the full profile